Organon & Co
818 hedge funds and large institutions have $6.64B invested in Organon & Co in 2022 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 207 increasing their positions, 378 reducing their positions, and 173 closing their positions.
68% more call options, than puts
Call options by funds: $35.1M | Put options by funds: $20.8M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
21% more capital invested
Capital invested by funds: $5.51B → $6.64B (+$1.13B)
3.31% more ownership
Funds ownership: 71.66% → 74.97% (+3.3%)
10% less funds holding
Funds holding: 907 → 818 (-89)
45% less first-time investments, than exits
New positions opened: 96 | Existing positions closed: 173
45% less repeat investments, than reductions
Existing positions increased: 207 | Existing positions reduced: 378
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$284M |
| 2 |
Janus Henderson Group
London,
|
+$145M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$124M |
| 4 |
State Street
Boston,
Massachusetts
|
+$88.9M |
| 5 |
SCM
Smead Capital Management
Phoenix,
Arizona
|
+$34.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$91.2M |
| 2 |
JP Morgan Chase
New York
|
-$51.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$33.7M |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$33.4M |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$31.2M |
OGN Hedge Fund Activity: Q1 2022 in Review
818 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q1 2022, worth a combined $6.64B — up 21% from $5.51B a quarter earlier.
Sellers outnumbered buyers: 173 funds closed out of OGN and 96 opened new positions — a net loss of 77 holders — while 378 trimmed existing stakes and 207 added.
The largest buyer was Mawer Investment Management, opening a new position worth an estimated $284M. The largest seller was Charles Schwab, cutting an estimated $91.2M.
- 818 institutional investors held Organon & Co (OGN) as of Q1 2022, down from 907 in Q4 2021.
- Funds reported $6.64B of Organon & Co stock for Q1 2022, up 21% quarter-over-quarter.
- 96 funds opened new Organon & Co positions in Q1 2022 and 173 closed out, a net change of -77 holders.
- The largest Organon & Co buyer in Q1 2022 was Mawer Investment Management, an estimated $284M added.
- The largest Organon & Co seller in Q1 2022 was Charles Schwab, an estimated $91.2M sold.
Based on aggregated 13F filings for Q1 2022.